Questions About Cancer? 1-800-4-CANCER
  • Posted: 01/10/2014
NCI Cancer Center News

Study shows promise for preventing therapy resistance in tumor cells

A new study led by University of Kentucky researchers suggests that activating the tumor suppressor p53 in normal cells causes them to secrete Par-4, another potent tumor suppressor protein that induces cell death in cancer cells. This finding may help researchers decipher how to inhibit the growth of tumors that have become resistant to other treatments. The University of Kentucky is home to the UK Markey Cancer Center.

Click here to read full press release.

###

NCI cancer centers logo

Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.